TRANSVAC: European Training in Vaccinology

First call for training modules

Training scientists in vaccine research and development (R&D) is crucial in order to sustain Europe’s excellence in this field. The TRANSVAC2 Consortium has set up training modules at leading European centers that can be combined to create customised international courses on vaccine R&D. Two rounds of customised training courses are planned. Participants can select topics as needed in their field of vaccine development and the timelines of the various modules are harmonized in a way that allows a logical continuation from one topic to the other.

Calls for application to the various training modules will be launched from June 2018 to February 2022, with subsequent deadlines one month after the launch of each call.

The first call is open from 1st June 2018 – 1st July 2018. It will cover for the following 2 training modules:

  • M1 : Clinical vaccine development and Biomanufacturing, conducted at University of Oxford from 15-18 October 2018
  • M2 : Human and veterinary vaccine development, conducted at University of Oxford from 19-23 November 2018.

Participants will be selected by a course selection panel.

Courses are offered free of charge. However selected applicants will have to cover their own travel and visa expenses for some courses also their accommodation.

Candidates working in a European Union Member State or Associated Member State are eligible to apply. Candidates from other countries who are working in vaccine development projects funded by the European Commission (EC) or European and Developing Countries Clinical Trials Partnership (EDCTP) will also be eligible to apply. Other candidates can also apply, but priority will be given to the groups mentioned above.

For more information about the training modules offered by TRANSVAC, the eligibility criteria and the application process, please visit:

If you have any specific questions, you can contact the project management team at:

Please spread information about this call among your colleagues working in or promoting research in vaccine development.